Adaptimmune Therapeutics vs Quince Therapeutics
Adaptimmune Therapeutics vs Quince Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptimmune Therapeutics is on 44/100 and Quince Therapeutics on 37/100.
Where each one leads
Adaptimmune Therapeutics
- our overall score: 44/100 against 37/100
- domain rating: 52/100 against 38/100
- funding raised: $107M against $63.0M
Quince Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adaptimmune Therapeutics | Quince Therapeutics |
|---|---|---|
| What it is | Biopharmaceutical company developing T-cell therapies for solid tumor cancers. | A biopharmaceutical company focused on developing novel therapies. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Cancer Immunotherapy | Biotechnology, Pharmaceuticals, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2008 | 2020 |
| Headquarters | Abingdon, United Kingdom | South San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptimmune Therapeutics | Quince Therapeutics |
|---|---|---|
| Employees | 191 | Not published |
| Total funding | $107M | $63.0M |
| Latest round | Series A | Series C |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 54,208 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptimmune Therapeutics | Quince Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 37/100 |
| Traction | 60/100 | 39/100 |
| Team | 30/100 | Not published |
| Search visibility | 30/100 | 13/100 |
| Quality | 45/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (38/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 52/100 | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptimmune Therapeutics | Quince Therapeutics |
|---|---|---|
| Hosting | AWS | AWS |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Analytics 4, Linkedin Insight | Jetpack Stats |
Adaptimmune Therapeutics vs Quince Therapeutics: common questions
Which is better, Adaptimmune Therapeutics or Quince Therapeutics?
On our 0-100 score Adaptimmune Therapeutics rates higher (44/100 against 37/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Adaptimmune Therapeutics and Quince Therapeutics compare on the numbers?
Adaptimmune Therapeutics leads on our overall score (44/100 against 37/100), domain rating (52/100 against 38/100), funding raised ($107M against $63.0M).
Read the full Adaptimmune Therapeutics review and pricing or the Quince Therapeutics review and pricing. You can also browse other Adaptimmune Therapeutics alternatives we track.